EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent

Pradeep Khanal, Suhail Sapkota, Ioannis Karageorgiou, Tareq Al Baghdadi

Cureus · 20.04.2026

DOI: 10.7759/cureus.107424 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 20.04.2026. Verfasst von Pradeep Khanal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Oncology, Henry Ford Health, Detroit, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

acquired hypofibrinogenemiadrug-induced coagulopathyeravacyclinefibrinogen monitoringtetracycline

Autor:innen und Institutionen

  • Hematology and Oncology, Henry Ford Health, Detroit, USA.
  • Internal Medicine, University of Michigan Health-Sparrow, Lansing, USA.
  • Internal Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, USA.
  • Hematology and Oncology, St Joseph Mercy Hospital, Ypsilanti, USA.

Zitieren

APA

Khanal, P., Sapkota, S., Karageorgiou, I., & Al Baghdadi, T. (2026). Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent. Cureus. https://doi.org/10.7759/cureus.107424

Vancouver

Khanal P, Sapkota S, Karageorgiou I, Al Baghdadi T. Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent. Cureus. 2026. doi:10.7759/cureus.107424

BibTeX
@article{Khanal2026,
  author = {Khanal, Pradeep and Sapkota, Suhail and Karageorgiou, Ioannis and Al Baghdadi, Tareq},
  title = {Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.107424}
}
Kostenlos starten →